DK1380121T3 - Fremgangsmåde til fremstilling af oxazolidinoner - Google Patents

Fremgangsmåde til fremstilling af oxazolidinoner

Info

Publication number
DK1380121T3
DK1380121T3 DK02725224T DK02725224T DK1380121T3 DK 1380121 T3 DK1380121 T3 DK 1380121T3 DK 02725224 T DK02725224 T DK 02725224T DK 02725224 T DK02725224 T DK 02725224T DK 1380121 T3 DK1380121 T3 DK 1380121T3
Authority
DK
Denmark
Prior art keywords
oxazolidinones
preparation
Prior art date
Application number
DK02725224T
Other languages
Danish (da)
English (en)
Inventor
William R Perrault
Bruce A Pearlman
Delara B Godrej
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26963272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1380121(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of DK1380121T3 publication Critical patent/DK1380121T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
DK02725224T 2001-04-20 2002-04-15 Fremgangsmåde til fremstilling af oxazolidinoner DK1380121T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28558601P 2001-04-20 2001-04-20
US36558102P 2002-03-19 2002-03-19
PCT/US2002/008261 WO2002085849A2 (en) 2001-04-20 2002-04-15 Process to prepare oxazolidinones

Publications (1)

Publication Number Publication Date
DK1380121T3 true DK1380121T3 (da) 2007-12-27

Family

ID=26963272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02725224T DK1380121T3 (da) 2001-04-20 2002-04-15 Fremgangsmåde til fremstilling af oxazolidinoner

Country Status (18)

Country Link
US (2) US6887995B2 (de)
EP (1) EP1380121B1 (de)
JP (1) JP2005504007A (de)
AR (1) AR035830A1 (de)
AT (1) ATE374463T1 (de)
AU (1) AU2002255803B2 (de)
CA (1) CA2440600A1 (de)
CY (1) CY1107003T1 (de)
DE (1) DE60222645T2 (de)
DK (1) DK1380121T3 (de)
ES (1) ES2291465T3 (de)
MX (1) MXPA03009645A (de)
MY (1) MY129372A (de)
NZ (1) NZ528996A (de)
PE (1) PE20021057A1 (de)
PT (1) PT1380121E (de)
TW (1) TWI252229B (de)
WO (1) WO2002085849A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2535796A1 (en) * 2003-08-22 2005-03-03 Pharmacia & Upjohn Company Llc N-aryl-2-cyanooxazolidinones and their derivatives
ES2803516T3 (es) 2003-10-16 2021-01-27 Symed Labs Ltd Una forma cristalina de linezolid
US7186844B2 (en) * 2004-01-13 2007-03-06 Mitsubishi Gas Chemical Co., Inc. Method for producing cyclic carbamate ester
CN100369909C (zh) * 2004-03-23 2008-02-20 中国科学院上海药物研究所 N-[4（r）－（1，3－二噁烷基）甲基]苯胺、制备方法和用途
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP2033960A3 (de) * 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
ITMI20072359A1 (it) * 2007-12-18 2009-06-19 Dipharma Francis Srl Procedimento per la preparazione di derivati ossazolidinonici
EP2163547A1 (de) 2008-09-16 2010-03-17 Unión Químico Farmacéutica, S.A. (UQUIFA) Verfahren für die Herstellung eines antibakteriellen Oxazolidinon-Wirkstoffs und Zwischenprodukte davon
CA2785620A1 (en) * 2009-12-26 2011-06-30 Alembic Pharmaceuticals Limited Process for the preparation of linezolid
CA2816515A1 (en) 2010-11-03 2012-05-10 Wockhardt Limited Process for the preparation of phosphoric acid mono-(1-{4-[(s)-5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-2,6-difluorophenyl}-4-methoxymethylpiperidin-4-yl) ester
CN102731336B (zh) 2011-04-12 2014-05-07 浙江医药股份有限公司新昌制药厂 利奈唑胺中间体及合成利奈唑胺的方法
CN102267955A (zh) * 2011-06-02 2011-12-07 山东鲁抗医药股份有限公司 一种利奈唑胺的制备方法
CN103130733B (zh) * 2011-12-02 2015-07-01 重庆圣华曦药业股份有限公司 制备利奈唑胺的方法
CN102516191B (zh) * 2011-12-21 2014-03-26 吉林省博大伟业制药有限公司 一种利奈唑胺的制备方法
CN102977056B (zh) * 2012-11-28 2014-11-26 深圳万乐药业有限公司 N-苄氧羰基-3-氟-4-吗啉基苯胺的合成方法
CN104140399A (zh) * 2013-05-08 2014-11-12 江苏豪森药业股份有限公司 利奈唑胺的制备方法
CN103483294B (zh) * 2013-08-12 2015-01-28 四川大学 3-氨基-2-丙醇乙酰胺类化合物的盐、其制备方法和用途
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide
CN105111160B (zh) * 2015-09-11 2017-04-12 浙江新东港药业股份有限公司 一种利奈唑胺的制备方法
US20170217911A1 (en) * 2015-12-18 2017-08-03 Mankind Research Centre Process For Preparation Of Linezolid
CN111077248A (zh) * 2019-12-24 2020-04-28 江苏乾元生物科技有限公司 Uplc-ms/ms检测(s)-1-氨基-3-氯-2-丙醇盐酸盐的方法
CN115219632B (zh) * 2022-07-29 2024-04-05 山东达因海洋生物制药股份有限公司 一种(s)-1-氨基-3-氯-2-丙醇盐酸盐的hplc-elsd检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
JPH10508844A (ja) * 1994-11-15 1998-09-02 ファルマシア・アンド・アップジョン・カンパニー 二環式オキサジンおよびチアジンオキサゾリジノン抗菌剤
EP0856002B1 (de) * 1995-09-01 2001-10-24 PHARMACIA & UPJOHN COMPANY Phenyloxazolidinone mit einer c-c-bindung zu 4-8 gliedrigen heterocyclen
MX9703040A (es) * 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
EP1114819B1 (de) * 1996-04-11 2008-01-09 Pharmacia & Upjohn Company LLC Verfahren zur Herstellung von Oxazolidinonen
CA2634657A1 (en) 1997-11-07 1999-05-20 Pharmacia & Upjohn Company Process to produce oxazolidinones
PE20020044A1 (es) 2000-06-16 2002-01-30 Upjohn Co Tiazina oxazolidinona

Also Published As

Publication number Publication date
DE60222645T2 (de) 2008-07-17
MY129372A (en) 2007-03-30
WO2002085849A2 (en) 2002-10-31
NZ528996A (en) 2006-01-27
AR035830A1 (es) 2004-07-14
EP1380121A2 (de) 2004-01-14
US7087784B2 (en) 2006-08-08
TWI252229B (en) 2006-04-01
PE20021057A1 (es) 2002-11-27
US20020169312A1 (en) 2002-11-14
PT1380121E (pt) 2007-11-21
ATE374463T1 (de) 2007-10-15
ES2291465T3 (es) 2008-03-01
MXPA03009645A (es) 2004-01-29
AU2002255803B2 (en) 2008-07-03
CY1107003T1 (el) 2012-09-26
US20040220407A1 (en) 2004-11-04
WO2002085849A3 (en) 2003-03-06
EP1380121B1 (de) 2007-09-26
DE60222645D1 (de) 2007-11-08
US6887995B2 (en) 2005-05-03
JP2005504007A (ja) 2005-02-10
CA2440600A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1451143T3 (da) Fremgangsmåder til fremstilling af O-desmethylvenlafaxin
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK1309582T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1296970T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1353930T3 (da) Fremgangsmåde til fremstilling af N-phosphonomethyliminodieddikesyre
DK1292586T3 (da) Fremgangsmåde til fremstilling af pyrazolopyrimidinoner
DK1268482T3 (da) Pyranoindoler til behandling af glaukom
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
DK1281707T3 (da) Fremgangsmåde til fremstilling af 5-substituerede isobenzenfuraner
DK1165483T3 (da) Fremgangsmåde til fremstilling af carbonylfluorid
DK1392711T3 (da) Fremgangsmåde til fremstilling af xylose